Loading market data...
Mon, 02 Nov 2026
10:59:25 am
Mon, 02 Nov 2026
10:59:25 am
Rudransh Sangwan
Published at: September 18, 2026, 6:38 AM
Synopsis
Sonaselection India IPO subscription status shows category-wise bidding from retail investors, NIIs and QIBs. Check the latest Day 2 subscription and IPO details.
The SpectraA Technology Solutions IPO was subscribed 5.66 times by Day 2 on September 18, 2026.
The company received bids for 1.36 crore shares against 23.96 lakh shares on offer. The IPO will close on September 21.
| Category | Subscription |
|---|---|
| Retail Individual Investors | 9.54x |
| Non Institutional Investors | 4.17x |
| Qualified Institutional Buyers | 0.00x |
| Total | 5.66x |
Retail investors subscribed 9.54 times their reserved portion.
The category received bids for 1.14 crore shares, making it the largest contributor to the overall subscription.
Non Institutional Investors subscribed 4.17 times their reserved portion.
Small NIIs subscribed 5.95x, while big NIIs subscribed 3.27x by Day 2.
The QIB category had not received bids by Day 2.
The category therefore remained at 0.00x subscription during the latest update.
| Particular | Details |
|---|---|
| Issue size | Rs 42.52 crore |
| Fresh issue | Rs 38.42 crore |
| OFS | Rs 4.11 crore |
| Fresh shares | 32.56 lakh |
| OFS shares | 3.48 lakh |
| Price band | Rs 112 to Rs 118 |
| Issue type | Fresh issue and OFS |
| IPO closes | September 21, 2026 |
| Retail minimum investment | Rs 2,83,200 |
| NII minimum investment | Rs 4,24,800 |
The SpectraA Technology Solutions IPO will remain open until September 21. Investors will track subscription demand across retail, NII and QIB categories.
Financial journalist specializing in market analysis, stock research, and investment trends. Dedicated to providing accurate, timely insights for informed decision-making.
Credentials: Experienced financial journalist with expertise in equity markets and economic analysis
The information provided in this article is for educational and informational purposes only and should not be construed as financial, investment, or legal advice. welomoney does not provide personalized investment recommendations.
For detailed terms and conditions, please read our Disclaimer and Terms of Service.
Motilal Oswal Q2 FY27 results show net profit rising 198% to ₹1,080 crore, revenue increasing 64% to ₹3,040 crore and EBITDA margin reaching 60.37%.
Bliss GVS Pharma Q2 FY27 results show revenue rising 37.3% to ₹261.13 crore, EBITDA jumping 161.4% and net profit increasing 196%.
Alivus Life Sciences Q2 FY27 results show net profit rising 51.3% to ₹196.8 crore, revenue growing 16% to ₹682 crore and EBITDA margin reaching 38.
Thyrocare Q2 FY27 revenue rose 25.1% to ₹270.81 crore, while net profit fell 66.9% to ₹15.89 crore amid a ₹44.98 crore impairment loss.
Patel Retail will invest ₹2 crore to add 20,000 sq ft to its Ambernath distribution centre, increasing covered area to 84,000 sq ft.
